Cholangitis is an infection caused due to a swelling to the common bile duct. This swelling is often a result of one or more gallstones in the gallbladder obstructing the flow of bile from the liver to the small intestine. Cholangitis can prove to be fatal and often leads to morbidity amongst patients. This bacterial infection can also be the result of a tumor in the bile duct.
Geriatrics Become Primary Growth Driver for Global Cholangitis Market
The global cholangitis market has been growing phenomenally due to the expanding geriatric pool, growing healthcare awareness, and rapidly changing lifestyles. Furthermore, more and more people being able to afford treatment for cholangitis with improving healthcare facilities and reimbursement policies has contributed to the growth of this market. As treatments for cholangitis have considerably improved life expectancy, the assurance amongst patients about the global cholangitis market is also building up. The population base above the age of 65 years, which is most susceptible to cholangitis, will be the primary growth driver for this market.
Early Diagnosis is Important to Treating Cholangitis
An individual who has a history of gallstones, sclerosing cholangitis, HIV, or a pancreatic cancer is more likely to develop cholangitis. Some of the commonly seen symptoms of cholangitis are fever, dark urine, nausea and vomiting, abdominal pain, jaundice, and low blood pressure. An early diagnosis is extremely crucial for treating and managing this disease. Diagnosing cholangitis at a later stage can make the case complicated and excruciatingly painful for the patient.
Antibiotics help in containing the infection that occurs in the biliary tract, and have thus become the most common treatment method for cholangitis. Depending on the case, an endoscopic retrograde cholangio-pancreatography (ERCP) can also be performed to remove stones or open strictures, which may have led to cholangitis. Surgery is typically the last resort in the case of patients who do not respond well to antibiotics or ERCP, which is non-invasive in nature.
Asia Pacific to Offer Lucrative Opportunities for Global Cholangitis Market
The global cholangitis market is segmented on the basis of geography into Asia Pacific, North America, Europe, and Rest of the World. Of these regions, North America holds a dominant position due to the growing geriatric population here. The market in North America is also being propelled by increasing healthcare awareness. According to research published by Transparency Market Research, the cholangitis market in Asia Pacific is likely to witness a good growth rate due to improved healthcare awareness. Furthermore, increasing per capita income in Asia Pacific, improving investments in the healthcare sector, and a huge population pool will bolster the cholangitis market in the region.
Companies shaping the future of the global cholangitis market are: Mayo Clinic, Zambon Company S.p.A., Gilead Sciences, RiemserArzneimittel AG, Bayer AG, and Taiho Pharmaceutical Co. Ltd. The various treatments designed by these companies and the outreach of their medicines will decide their fate in the global cholangitis market.
Brochure Download For Expert Suggestion:- http://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=2285
Transparency Market Research (TMR) is a next-generation provider of syndicated research, customized research, and consulting services. TMR’s global and regional market intelligence coverage includes industries such as pharmaceutical, chemicals and materials, technology and media, food and beverages, and consumer goods, among others. Each TMR research report provides clients with a 360-degree view of the market with statistical forecasts, competitive landscape, detailed segmentation, key trends, and strategic recommendations.
Transparency Market Research
90 State Street,
Albany NY – 12207